EMA — authorised 9 November 2016
- Marketing authorisation holder: Pfizer Limited
- Status: approved
🇪🇺 Ibrance in European Union
EMA authorised Ibrance on 9 November 2016
Marketing authorisation
Ibrance in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Ibrance approved in European Union?
Yes. EMA authorised it on 9 November 2016.
Who is the marketing authorisation holder for Ibrance in European Union?
Pfizer Limited holds the EU marketing authorisation.